Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2C8 | P10632 | 6/20 | 0.48 |
| ▸ | CYP3A4 | P08684 | 5/20 | 0.48 |
| ▸ | ROCK2 | O75116 | 1/20 | 0.40 |
| ▸ | ROCK1 | Q13464 | 1/20 | 0.40 |
| ▸ | KCNH2 | Q12809 | 3/20 | 0.39 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.39 |
| ▸ | SLC6A9 | P48067 | 1/20 | 0.36 |
| ▸ | TGFBR1 | P36897 | 1/20 | 0.35 |
| ▸ | ABL1 | P00519 | 4/20 | 0.35 |
| ▸ | MAPK14 | Q16539 | 1/20 | 0.34 |
| ▸ | MAPK8 | P45983 | 1/20 | 0.34 |
| ▸ | EPHB3 | P54753 | 1/20 | 0.33 |
| ▸ | MAPK13 | O15264 | 1/20 | 0.33 |
| ▸ | F9 | P00740 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1935003 | 0.86 | EPHB3 (0.40) | CYP2C8CYP3A4ROCK2ROCK1TGFBR1 | |
| SCHEMBL1936906 | 0.77 | NPC1 (0.42) | CYP2C8CYP3A4MAPK8EPHB3 | |
| SCHEMBL1934831 | 0.77 | CYP2C8 (0.61) | CYP2C8CYP3A4ROCK2ROCK1KCNH2 | |
| SCHEMBL9911902 | 0.74 | CYP2C8 (0.62) | CYP2C8CYP3A4ROCK2ROCK1KCNH2 | |
| SCHEMBL13241638 | 0.70 | CYP2C8 (0.59) | CYP2C8CYP3A4ROCK2ROCK1KCNH2 | |
| SCHEMBL1935412 | 0.69 | CYP2C8 (0.57) | CYP2C8CYP3A4KCNH2NR1I2ABL1 | |
| SCHEMBL667045 | 0.69 | CYP2C8 (0.59) | CYP2C8CYP3A4ROCK2ROCK1KCNH2 | |
| SCHEMBL666705 | 0.68 | CYP2C8 (0.46) | CYP2C8CYP3A4ROCK2ROCK1KCNH2 | |
| SCHEMBL12187969 | 0.68 | CYP2C8 (0.56) | CYP2C8CYP3A4ROCK2ROCK1KCNH2 | |
| SCHEMBL1936894 | 0.68 | CYP2C8 (0.55) | CYP2C8CYP3A4KCNH2NR1I2ABL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2331502-A2 | COMPOUNDS FOR THE TREATMENT OF HEPATITIS C | Bristol-Myers Squibb Company (US) | 2011-06-15 | — | — | EP | disclosed |
| WO-2010030538-A2 | COMPOUNDS FOR THE TREATMENT OF HEPATITIS C | BRISTOL-MYERS SQUIBB COMPANY (US) | 2010-03-18 | — | — | WO | disclosed |